Skip to main content
Table of Contents
Print

Can Medical Cannabis Help Treat Obstructive Sleep Apnoea? 

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Obstructive sleep apnoea (OSA) is a common sleep disorder characterised by repeated airway obstruction during sleep. Researchers and patients are exploring whether medical cannabis for sleep apnoea could be a potential therapeutic option. Understanding its effects on breathing patterns and sleep quality is crucial. 

Potential Benefits of Cannabis in OSA 

Studies suggest medical cannabis for sleep apnoea may influence respiratory function and promote better sleep quality. 

Airway Muscle Relaxation 

Cannabinoids may help reduce airway collapsibility, supporting cannabis treatment for OSA. 

Sleep Pattern Improvement 

Certain cannabis compounds could enhance sleep continuity and reduce awakenings in OSA patients, contributing to marijuana therapy for sleep disorder. 

Inflammation Reduction 

Cannabis may lower inflammation in the upper airway, potentially improving breathing during sleep and supporting cannabis treatment for OSA. 

Symptom Relief 

Some patients report decreased daytime sleepiness and improved restfulness, suggesting benefits of medical cannabis for sleep apnoea. 

Adjunctive Therapy Potential 

Medical cannabis may complement existing OSA therapies, such as CPAP, as part of marijuana therapy for sleep disorder. 

While evidence is still emerging, medical cannabis for sleep apnoea shows promise as a supportive treatment. Further research is needed to confirm safety, optimal dosing, and long-term outcomes for cannabis treatment for OSA. 

If you’re exploring cannabis treatment options for obstructive sleep apnoea, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Obstructive Sleep Apnoea . 

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories